Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination dosage form of a mu opioid receptor antagonist and an opioid agent

Combination dosage form of a mu opioid receptor antagonist and an opioid agent

US Patent 11452723 · Granted Sep 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxabicyclo acids as LPA antagonists2025
Pediococcus acidilactici CCFM6432 for alleviating depression, food fermented the2025
Strain of lactobacillus fermentum capable of preventing and/or treating periodon2025
Isoxazole carboxylic acids as LPA antagonists2025
Multifunctional lactobacillus capable of relieving PFOA toxic effects and applic2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Device for mass transfer of mini light-emitting diodes (mini-LEDs) based on arra2025
Recombinant severe respiratory syndrome coronavirus 2 Rbd trimer protein vaccine2025
Anti-inflammatory coupling compound drug, and preparation method therefor and us2025
Bifidobacterium breve capable of relieving rheumatoid arthritis and application 2025
Method for manufacturing a humidity alarm device based on laser-induced graphene2025
Method for mass transfer of mini light-emitting diodes (mini-LEDs) using sliding2025